Is Severity of Adverse Events Affected by the Dose and Frequency of Glatiramer Acetate Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)?

被引：0
|
作者：
Wu, Y. [1 ]
Gandhi, S. [1 ]
Grinspan, A. [1 ]
Kolodny, S. [2 ]
Zagmutt, F. J. [3 ]
机构：
[1] Teva Pharmaceut Ind, Frazer, PA USA
[2] Teva Pharmaceut Ind, Cleveland, OH USA
[3] EpiX Analyt, Boulder, CO USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-45
引用
收藏
页码：333 / 333
页数：1
相关论文
共 50 条
  • [1] IS SEVERITY OF ADVERSE EVENTS AFFECTED BY THE DOSE AND FREQUENCY OF GLATIRAMER ACETATE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS?
    Zagmutt, Francisco
    Wu, Ying
    Grinspan, Augusto
    Kolodny, Scott
    Gandhi, Sanjay
    [J]. NEUROLOGY, 2016, 86
  • [2] Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis
    Johnson, Kenneth P.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (04) : 371 - 384
  • [3] Evaluating the response to glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patients
    Rio, Jordi
    Rovira, Alex
    Tintore, Mar
    Sastre-Garriga, Jaurne
    Castillo, Joaquin
    Auger, Cristina
    Nos, Carlos
    Comabella, Manuel
    Tur, Carmen
    Vidal, Angela
    Montalban, Xavier
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (12) : 1602 - 1608
  • [4] Spotlight on glatiramer acetate in relapsing-remitting multiple sclerosis
    Simpson, D
    Noble, S
    Perry, C
    [J]. BIODRUGS, 2003, 17 (03) : 207 - 210
  • [5] Spotlight on Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis
    Dene Simpson
    Stuart Noble
    Caroline Perry
    [J]. BioDrugs, 2003, 17 : 207 - 210
  • [6] Glatiramer acetate: Promise in relapsing-remitting multiple sclerosis?
    不详
    [J]. Drugs & Therapy Perspectives, 1998, 11 (10) : 1 - 5
  • [7] Erythema nodosum and glatiramer acetate treatment in relapsing-remitting multiple sclerosis
    Thouvenot, E.
    Hillaire-Buys, D.
    Bos-Thompson, M. A.
    Rigau, V.
    Durand, L.
    Guillot, B.
    Camu, W.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2007, 13 (07) : 941 - 944
  • [8] Experience of Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients
    Taskapilioglu, Ozlem
    Turan, Asli Bahar
    Albas, Murat
    Turan, Omer Faruk
    [J]. TURKISH JOURNAL OF NEUROLOGY, 2012, 18 (01) : 17 - 20
  • [9] Time Course of Glatiramer Acetate Efficacy in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS) in the Glatiramer Acetate Low-Frequency Administration (GALA) Study
    Kolodny, S.
    Davis, M. D.
    Ashtamker, N.
    Steinerman, J. R.
    Knappertz, V.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (02) : 333 - 334
  • [10] Investigating glatiramer acetate for relapsing-remitting multiple sclerosis at the double dose - is more better?
    Calabresi, Peter A.
    [J]. NATURE CLINICAL PRACTICE NEUROLOGY, 2007, 3 (10): : 540 - 541
12345